PBYI
#2959
Puma Biotechnology Inc - Common Stock
9.0 6 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.95%
Changement Mensuel
+16.30%
Evolution sur 6 mois
+64.43%
Changement Annuel
+79.41%
Clôture Précédente
9.2 4
Open
9.0 6
Low
9.0 6
High
9.0 6
Volume
59
Financials
- Market Capitalization 467.68 M
- Employee 179
- Founded 2007
- CEO N/A
- Website www.pumabiotechnology.com
- Headquarter Delaware, United States
- FIGI BBG0018YXYX7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
9.75
ratio cours/chiffre d'affaires
1.32
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2944 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.33 USD | +2.64% | -1.37% | +9.76% | +14.20% | 478.97 M USD | ||
| 2954 |  CCCC C4 Therapeutics, Inc. - Common Stock | 3.85 USD | -6.10% | -3.02% | +9.07% | +49.81% | 473.65 M USD | ||
| 2968 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.33 USD | -4.20% | -6.68% | -17.05% | +283.19% | 461.88 M USD | ||
| 2981 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 13.17 USD | -4.84% | -0.30% | +3.70% | -10.41% | 449.98 M USD |